EUVIMEDEUVIMED entdecken
Crossref

Current burden and health care utilization of inflammatory bowel disease in the United States, 2023–2024

Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, Sidhartha R Sinha, Aijaz Ahmed

Intestinal Research · 11.06.2026

DOI: 10.5217/ir.2026.00046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Intestinal Research, online erschienen am 11.06.2026. Verfasst von Donghee Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA. dhkimmd90@gmail.com. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is a chronic condition resulting in inflammation of the gastrointestinal tract. 1 There are 2 main types of IBD: Crohn’s disease (CD) and ulcerative colitis (UC). 1 Despite its importance, national estimates of IBD are outdated. 1 The most current nationwide study using data from the National Health Interview Survey (NHIS) was published in 2016, using data from the 2015 NHIS. This study estimated that 3.1 million people, or 1.2% of the adult population, have IBD in the United States. 1 Given the absence of more recent estimates of IBD in adults in the United States, an update is warranted. Individuals with

Autor:innen und Institutionen

  • Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA. dhkimmd90@gmail.com.
  • Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
  • Division of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Phoenix, AZ, USA.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Banner - University Medical Center, Phoenix, AZ, USA.
  • Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA.

Zitieren

APA

Kim, D., Danpanichkul, P., Wijarnpreecha, K., Sinha, S. R., & Ahmed, A. (2026). Current burden and health care utilization of inflammatory bowel disease in the United States, 2023–2024. Intestinal Research. https://doi.org/10.5217/ir.2026.00046

Vancouver

Kim D, Danpanichkul P, Wijarnpreecha K, Sinha SR, Ahmed A. Current burden and health care utilization of inflammatory bowel disease in the United States, 2023–2024. Intestinal Research. 2026. doi:10.5217/ir.2026.00046

BibTeX
@article{Kim2026,
  author = {Kim, Donghee and Danpanichkul, Pojsakorn and Wijarnpreecha, Karn and Sinha, Sidhartha R and Ahmed, Aijaz},
  title = {Current burden and health care utilization of inflammatory bowel disease in the United States, 2023–2024},
  journal = {Intestinal Research},
  year = {2026},
  doi = {10.5217/ir.2026.00046}
}
Kostenlos starten →